Use of betapropiolactone to disinfect fresh tissue without impairing antigenicity: method applicable to human immunodeficiency virus (HIV) positive tissue.
Open Access
- 1 March 1989
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 42 (3) , 318-321
- https://doi.org/10.1136/jcp.42.3.318
Abstract
A method for inactivating viruses in tissues is reported that does not impair the antigenicity of the Coxsackie virus or of some common tissue antigens, a common problem with standard tissue fixation methods. Tissues can be placed briefly in Betapropiolactone before cryostat sectioning without any adverse effect on preservation or antigen expression. It is suggested that use of Betapropiolactone is applicable to tissues harbouring or exposed to the human immunodeficiency virus (HIV). As betapropiolactone has been reported to be carcinogenic in rodents any potential danger can be avoided by basic simple precautions.This publication has 5 references indexed in Scilit:
- The Detection of Coxsackievirus RNA in Cardiac Tissue by in situ HybridizationJournal of General Virology, 1988
- Effect of β-propiolactone — an inhibitor of HTLV III/LAV activity — on immunological analysesJournal of Immunological Methods, 1986
- MEASLES VIRUS INFECTION WITHOUT RASH IN CHILDHOOD IS RELATED TO DISEASE IN ADULT LIFEThe Lancet, 1985
- EFFECT OF BETA-PROPIOLACTONE IN BLOOD ON ROUTINE HAEMATOLOGICAL, BIOCHEMICAL, AND SEROLOGICAL INVESTIGATIONSThe Lancet, 1982
- CARCINOGENIC LACTONES AND RELATED SUBSTANCESBritish Medical Bulletin, 1964